170 related articles for article (PubMed ID: 38127169)
1. Using PROMIS-29 to determine symptom burdens in the context of the Type 1 and 2 systemic lupus erythematosus (SLE) model: a cross sectional study.
Sun K; Eudy AM; Harris N; Pisetsky DS; Criscione-Schreiber LG; Sadun RE; Doss J; Clowse MEB; Rogers JL
J Patient Rep Outcomes; 2023 Dec; 7(1):136. PubMed ID: 38127169
[TBL] [Abstract][Full Text] [Related]
2. The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activity.
Eudy AM; Reeve BB; Coles T; Lin L; Rogers JL; Pisetsky DS; Criscione-Schreiber LG; Doss J; Sadun R; Sun K; Clowse ME
Lupus; 2022 May; 31(6):697-705. PubMed ID: 35343853
[TBL] [Abstract][Full Text] [Related]
3. Fatigue, patient reported outcomes, and objective measurement of physical activity in systemic lupus erythematosus.
Mahieu MA; Ahn GE; Chmiel JS; Dunlop DD; Helenowski IB; Semanik P; Song J; Yount S; Chang RW; Ramsey-Goldman R
Lupus; 2016 Oct; 25(11):1190-9. PubMed ID: 26869353
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Type 2 SLE symptoms in patients with a range of lupus nephritis activity.
Rogers JL; Clowse MEB; Pisetsky DS; Criscione-Schreiber LG; Sun K; Sadun RE; Maheswaranathan M; Burshell DR; Doss J; Eudy AM
Clin Rheumatol; 2024 Apr; 43(4):1319-1326. PubMed ID: 38409491
[TBL] [Abstract][Full Text] [Related]
5. Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus.
Kasturi S; Szymonifka J; Burket JC; Berman JR; Kirou KA; Levine AB; Sammaritano LR; Mandl LA
J Rheumatol; 2017 Jul; 44(7):1024-1031. PubMed ID: 28412708
[TBL] [Abstract][Full Text] [Related]
6. Using Clinical Characteristics and Patient-Reported Outcome Measures to Categorize Systemic Lupus Erythematosus Subtypes.
Rogers JL; Eudy AM; Pisetsky D; Criscione-Schreiber LG; Sun K; Doss J; Clowse MEB
Arthritis Care Res (Hoboken); 2021 Mar; 73(3):386-393. PubMed ID: 31909888
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of health-related quality of life in patients with systemic lupus erythematosus using PROMIS and Neuro-QoL.
Lai JS; Beaumont JL; Jensen SE; Kaiser K; Van Brunt DL; Kao AH; Chen SY
Clin Rheumatol; 2017 Mar; 36(3):555-562. PubMed ID: 27848056
[TBL] [Abstract][Full Text] [Related]
8. Development and psychometric evaluation of a physician global assessment for type 2 systemic lupus erythematosus symptoms.
Clowse MEB; Rogers JL; Coles T; Pisetsky DS; Criscione-Schreiber LG; Burshell D; Doss J; Sadun RE; Sun K; Maheswaranathan M; Eudy AM
Lupus Sci Med; 2023 Dec; 10(2):. PubMed ID: 38105242
[TBL] [Abstract][Full Text] [Related]
9. Feasibility, Validity, and Reliability of the 10-item Patient Reported Outcomes Measurement Information System Global Health Short Form in Outpatients with Systemic Lupus Erythematosus.
Kasturi S; Szymonifka J; Burket JC; Berman JR; Kirou KA; Levine AB; Sammaritano LR; Mandl LA
J Rheumatol; 2018 Mar; 45(3):397-404. PubMed ID: 29419473
[TBL] [Abstract][Full Text] [Related]
10. Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).
Chaigne B; Chizzolini C; Perneger T; Trendelenburg M; Huynh-Do U; Dayer E; Stoll T; von Kempis J; Ribi C;
BMC Immunol; 2017 Mar; 18(1):17. PubMed ID: 28351341
[TBL] [Abstract][Full Text] [Related]
11. Validation of Patient-Reported Outcomes Measurement Information System Short Forms for Use in Childhood-Onset Systemic Lupus Erythematosus.
Jones JT; Carle AC; Wootton J; Liberio B; Lee J; Schanberg LE; Ying J; Morgan DeWitt E; Brunner HI
Arthritis Care Res (Hoboken); 2017 Jan; 69(1):133-142. PubMed ID: 27111350
[TBL] [Abstract][Full Text] [Related]
12. Major Depression and Adverse Patient-Reported Outcomes in Systemic Lupus Erythematosus: Results From a Prospective Longitudinal Cohort.
Dietz B; Katz P; Dall'Era M; Murphy LB; Lanata C; Trupin L; Criswell LA; Yazdany J
Arthritis Care Res (Hoboken); 2021 Jan; 73(1):48-54. PubMed ID: 32741124
[TBL] [Abstract][Full Text] [Related]
13. Axl, Ferritin, Insulin-Like Growth Factor Binding Protein 2, and Tumor Necrosis Factor Receptor Type II as Biomarkers in Systemic Lupus Erythematosus.
Mok CC; Ding HH; Kharboutli M; Mohan C
Arthritis Care Res (Hoboken); 2016 Sep; 68(9):1303-9. PubMed ID: 26749069
[TBL] [Abstract][Full Text] [Related]
14. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.
Oke V; Gunnarsson I; Dorschner J; Eketjäll S; Zickert A; Niewold TB; Svenungsson E
Arthritis Res Ther; 2019 Apr; 21(1):107. PubMed ID: 31036046
[TBL] [Abstract][Full Text] [Related]
15. Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus.
Mertz P; Piga M; Chessa E; Amoura Z; Voll RE; Schwarting A; Maurier F; Blaison G; Bonnotte B; Poindron V; Fiehn C; Lorenz HM; Korganow AS; Sibilia J; Martin T; Arnaud L
RMD Open; 2022 Sep; 8(2):. PubMed ID: 36123013
[TBL] [Abstract][Full Text] [Related]
16. Serum adipokine levels and associations with patient-reported fatigue in systemic lupus erythematosus.
Mahieu MA; Ahn GE; Chmiel JS; Dunlop DD; Helenowski IB; Semanik P; Song J; Yount S; Chang RW; Ramsey-Goldman R
Rheumatol Int; 2018 Jun; 38(6):1053-1061. PubMed ID: 29302804
[TBL] [Abstract][Full Text] [Related]
17. Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN).
Williams-Hall R; Berry P; Williamson N; Barclay M; Roberts A; Gater A; Tolley C; Bradley H; Ward A; Hsia E; Zuraw Q; DeLong P; Touma Z; Strand V
Lupus Sci Med; 2022 Aug; 9(1):. PubMed ID: 36007978
[TBL] [Abstract][Full Text] [Related]
18. Construct validity of Patient-Reported Outcomes Measurement Information System Paediatric measures in juvenile idiopathic arthritis and systemic lupus erythematosus: cross-sectional evaluation.
Weitzman ER; Gaultney A; von Scheven E; Ringold S; Mann CM; Magane KM; Lin L; Leverty R; Dennos A; Hernandez A; Lippmann SJ; Dedeoglu F; Marin AC; Cox R; Reeve BB; Schanberg LE
BMJ Open; 2023 Jan; 13(1):e063675. PubMed ID: 36707118
[TBL] [Abstract][Full Text] [Related]
19. Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms.
Askanase AD; Castrejón I; Pincus T
J Rheumatol; 2011 Jul; 38(7):1309-16. PubMed ID: 21459938
[TBL] [Abstract][Full Text] [Related]
20. The Fatigue Assessment Scale as a simple and reliable tool in systemic lupus erythematosus: a cross-sectional study.
Horisberger A; Courvoisier D; Ribi C
Arthritis Res Ther; 2019 Mar; 21(1):80. PubMed ID: 30909957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
